SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bioterrorism

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject7/17/2003 12:58:12 PM
From: tuck   of 891
 
>>Published online before print July 17, 2003
Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1233578100

Immunology
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

Igor M. Belyakov *, Patricia Earl , Amiran Dzutsev *, Vladimir A. Kuznetsov , Michael Lemon *, Linda S. Wyatt , James T. Snyder *, Jeffrey D. Ahlers *, Genoveffa Franchini ¶, Bernard Moss , and Jay A. Berzofsky *
*Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch, and ¶Basic Research Laboratory, National Cancer Institute, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, and Laboratory of Integrative and Medical Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892

Contributed by Bernard Moss, June 10, 2003

The concern about bioterrorism with smallpox has raised the possibility of widespread vaccination, but the greater prevalence of immunocompromised individuals today requires a safer vaccine, and the mechanisms of protection are not well understood. Here we show that, at sufficient doses, the protection provided by both modified vaccinia Ankara and NYVAC replication-deficient vaccinia viruses, safe in immunocompromised animals, was equivalent to that of the licensed Wyeth vaccine strain against a pathogenic vaccinia virus intranasal challenge of mice. A similar variety and pattern of immune responses were involved in protection induced by modified vaccinia Ankara and Wyeth viruses. For both, antibody was essential to protect against disease, whereas neither effector CD4+ nor CD8+ T cells were necessary or sufficient. However, in the absence of antibody, T cells were necessary and sufficient for survival and recovery. Also, T cells played a greater role in control of sublethal infection in unimmunized animals. These properties, shared with the existing smallpox vaccine, provide a basis for further evaluation of these replication-deficient vaccinia viruses as safer vaccines against smallpox or against complications from vaccinia virus.<<

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext